Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Formoterol (12mcg) + Tiotropium (18mcg)
Therapeutic Category
Pulmonary, Respiratory, Asthma
Dosage Form
Inhaler
Packaging Type
with Carton and Leaflet
Packaging
200 Metered Dose
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tropiturn F 12/18 Inhaler combines Formoterol (12mcg) and Tiotropium (18mcg), two effective bronchodilators, to provide relief from symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma. Formoterol, a long-acting beta-agonist (LABA), helps in relaxing the muscles of the airways, while Tiotropium, an anticholinergic agent, helps to open the airways by blocking the action of acetylcholine, a chemical that constricts the muscles. Together, these components provide dual action, improving airflow, reducing bronchospasms, and preventing symptoms like wheezing, coughing, and shortness of breath.
Tropiturn F 12/18 Inhaler is designed for patients with COPD or asthma, where managing airway constriction is essential to improving quality of life and reducing flare-ups. Regular use as prescribed can help manage chronic respiratory symptoms, reduce exacerbations, and provide long-term relief.
Common side effects may include dry mouth, cough, throat irritation, or dizziness. Serious side effects such as chest pain or irregular heartbeats are rare but require immediate medical attention.
For the management of chronic obstructive pulmonary disease (COPD) and asthma.
Not for use in acute bronchospasm. Use as directed and consult a healthcare provider if adverse effects occur.
Store in a cool, dry place away from heat and direct sunlight. Keep out of the reach of children.
Composition : Tiotropium (9mcg)
Composition : Levosalbutamol (50mcg) + Ipratropium (20mcg)
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
Composition : Levosalbutamol (100mcg) + Ipratropium (80mcg)
Composition : Salmeterol (50mcg) + Fluticasone Propionate (500 mcg)
Composition : Levosalbutamol (0.5mg/5ml) + Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Formoterol 12mcg + Tiotropium 18mcg Inhaler has strong demand in the respiratory, pulmonology, and chronic disease management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on COPD and asthma care portfolios.
Medical distributors and agencies can benefit from consistent demand for long-term respiratory disease management under medical supervision. Formoterol 12mcg is a long-acting beta-2 agonist (LABA) that helps relax airway muscles and improve breathing Tiotropium 18mcg is a long-acting muscarinic antagonist (LAMA) that helps keep airways open for longer duration Commonly prescribed for COPD (chronic obstructive pulmonary disease), bronchial asthma, chronic bronchitis, and breathing difficulty conditions Provides dual bronchodilation for improved lung function and long-term respiratory control Widely used by pulmonologists and respiratory specialists for maintenance therapy This strengthens a comprehensive respiratory care and chronic disease portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Formoterol 12mcg + Tiotropium 18mcg Inhaler with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong chronic disease demand, long-term prescriptions, repeat monthly purchases, hospital and pulmonology prescriptions, reliable supply chain support, and attractive margins in the respiratory segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.